Navigation Links
Parkinson's Institute research shows that nicotine reduces levodopa-induced dyskinesias
Date:10/24/2007

SUNNYVALE, Calif., October 24, 2007 The Parkinsons Institute and Clinical Center today announced research showing that intermittent nicotine treatment reduces medication-induced dyskinesias by as much as 50 percent in models of Parkinsons disease. Lead by senior research scientist, Maryka Quik, Ph.D., the research will be published in an upcoming issue of the Annals of Neurology.

Levodopa, the most common drug used to treat Parkinsons disease, is initially very effective. However, long-term treatment often lessens efficacy and causes multiple complications, including abnormal involuntary movements, called dyskinesias. These uncontrolled movements of the head and limbs tend to worsen over time and can become as debilitating as Parkinsons disease itself. Currently, there are only limited therapeutic options for dyskinesias, including reduction in levodopa dose, amantadine administration, and deep brain stimulation for a limited number of patients.

Most of the research on tobacco has focused on its detrimental health effects. Studies conducted over the last 40 years show that the incidence of Parkinsons disease is about 50 percent less in smokers than in the general population. Recent studies in experimental models suggest that the nicotine in smoke may be responsible for this neuroprotective effect. In addition, this is the first research to show that nicotine may also reduce levodopa-induced dyskinesias. With an estimated 1.5 million Parkinsons disease patients in the United States, and levodopa being the top prescribed medication for Parkinsons disease, this study has far-reaching implications for the treatment of Parkinsons disease.

Our hope is that this research represents a useful treatment strategy to reduce the dyskinesias that so many Parkinsons disease patients suffer, said Dr. Maryka Quik of the Parkinsons Institute and Clinical Center in Sunnyvale. Reducing the side effects of levodopa makes it a much more effective and long-term treatment.


'/>"/>

Contact: Alicia Swanson
alicia.swanson@comcast.net
408-836-7170
The Parkinson's Institute
Source:Eurekalert

Related medicine news :

1. Gambling related to Parkinsons medication
2. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
3. Highly Educated More Prone To Parkinsons Disease
4. Make Treatment of Parkinsons More Affordable, Doctors Plead
5. Parkinsons Disease can Be Predicted by Metabolic Pathway
6. Neural Stem Cells Reduce Parkinsons Symptoms in Monkeys
7. Risk of Parkinsons Increased by Exposure to Pesticide and Head Trauma
8. Coenzyme Q10 Does Not Improve Parkinsons Disease Symptoms
9. Patients Affected by Parkinsons may Be Benefited from Treadmill Exercise
10. UCLA Researchers Discover Link Between Parkinsons and Narcolepsy
11. First Ever Patch Drug To Treat Parkinsons Symptoms Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... 25, 2017 , ... Republicans in the United States Senate on Thursday released ... Care Reconciliation Act. It differs significantly from the American Health Care Act, which the ... committee, or the House will have to take up the Senate version as-is, if ...
(Date:6/24/2017)... , ... June 24, 2017 , ... ... offering genetic testing for medications in select Florida and Texas doctors' offices and ... , This new application of genetic testing recognizes the role genes play in ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality Institute ... Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate ... Alerts and Dashboards provide near real-time data about patients admitted to and/or discharged ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... The Military ... president's nominee for deputy secretary of Veterans Affairs, retired Marine Col. Thomas G. Bowman. ... Affairs. , Bowman brings an intimacy with the issues and challenges veterans ...
(Date:6/23/2017)... ... , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach ... proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does more ... can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... , June 14, 2017 The Bio ... City of Fremont and the ... the bio-pharma industry in California ... enabling executive networking, and fostering workforce development. The primary ... and growth of start-ups, as well as small and ...
(Date:6/12/2017)... 12, 2017 Kineta, Inc., a biotechnology company focused ... Vice President of R&D and Head of Virology Kristin ... Preparedness for the Northwest and Beyond meeting sponsored by ... 14, 2017 from 8:30-10:30 AM PDT at the Agora Conference ... Dr. Bedard will be joined by other leaders in ...
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
Breaking Medicine Technology: